Limited development and progression of resistance of HIV-1 to the nucleoside analogue reverse transcriptase inhibitor lamivudine in human primary macrophages

Journal of Antimicrobial Chemotherapy

Volumn 55, Issue 6, 2005, Pages 872-878

  Aquaro, Stefano ^a   Svicher, Valentina ^a   Ceccherini Silberstein, Francesca ^a   Cenci, Alessandra ^a   Marcuccilli, Fabbio ^a   Giannella, Sara ^a   Marcon, Luisa ^b   Caliò, Raffaele ^a   Balzarini, Jan ^c   Perno, Carlo Federico ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Fitness; M184V; Reservoirs

Indexed keywords

DEOXYRIBONUCLEOTIDE; LAMIVUDINE; NUCLEOSIDE ANALOG; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENETIC RESISTANCE; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; MACROPHAGE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; SITE DIRECTED MUTAGENESIS; SUPERNATANT; VIRUS MUTANT; VIRUS MUTATION; VIRUS REPLICATION; WILD TYPE;

ANTI-HIV AGENTS; CELLS, CULTURED; DRUG RESISTANCE, VIRAL; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; LAMIVUDINE; MACROPHAGES; MUTATION; REVERSE TRANSCRIPTASE INHIBITORS;

EID: 21244456885     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dki104     Document Type: Article

References (50)

1. Gartner, S., Markovits, P., Markovitz, D. M. et al. (1986). The role of mononuclear phagocytes in HTLV-III/LAV infection. Science 233, 215-9.
2. Meltzer, M. S. & Gendelman, H. E. (1992). Mononuclear phagocytes as targets, tissue reservoirs, and immunoregulatory cells in human immunodeficiency virus disease. Current Topics in Microbiology and Immunology 181, 239-63.
3. Lane, J. H., Sasseville, V. G., Smith, M. O. et al. (1996). Neuroinvasion by simian immunodeficiency virus coincides with increased numbers of perivascular macrophages/microglia and intrathecal immune activation. Journal of Neurovirology 2, 423-32.
4. Herbein, G., Coaquette, A., Perez-Bercoff, D. et al. (2002). Macrophage activation and HIV infection: can the Trojan horse turn into a fortress? Current Molecular Medicine 2, 723-38.
5. Koenig, S., Gendelman, H. E., Orenstein, J. M. et al. (1986). Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 233, 1089-93.
6. Tschachler, E., Groh, V., Popovic, M. et al. (1987). Epidermal Langerhans cells a target for HTLV-III/LAV infection. Journal of Investigative Dermatology 88, 233-7.
7. McElrath, M. J., Pruett, J. E. & Cohn, Z. A. (1989). Mononuclear phagocytes of blood and bone marrow: comparative roles as viral reservoirs in human immunodeficiency virus type 1 infections. Proceedings of the National Academy of Sciences, USA 86, 675-9.
8. Gabuzda, D. H., Ho, D. D., de la Monte, S. M. et al. (1986). Immunohistochemical identification of HTLV-III antigen in brains of patients with AIDS. Annals of Neurology 20, 289-95.
9. Giulian, D., Vaca, K. & Noonan, C. A. (1990). Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1. Science 250, 1593-6.
10. Tyor, W. R., Power, C., Gendelman, H. E. et al. (1993). A model of human immunodeficiency virus encephalitis in scid mice. Proceedings of the National Academy of Sciences, USA 90, 8658-62.
11. Crowe, S. M., Mills, J., Kirihara, J. et al. (1990). Full-length recombinant CD4 and recombinant gp120 inhibit fusion between HIV infected macrophages and uninfected CD4-expressing T-lymphoblastoid cells. AIDS Research and Human Retroviruses 6, 1031-7.
12. Badley, A. D., Dockrell, D., Simpson, M. et al. (1997). Macrophage-dependent apoptosis of CD4+ T lymphocytes from HIV-infected individuals is mediated by FasL and tumor necrosis factor. Journal of Experimental Medicine 185, 55-64.
13. Herbein, G., Mahlknecht, U., Batliwalla, F. et al. (1998). Apoptosis of CD8+ T cells is mediated by macrophages through interaction of HIV gp120 with chemokine receptor CXCR4. Nature 395, 189-94.
14. Garaci, E., Aquaro, S., Lapenta, C. et al. (2003). Anti-nerve growth factor Ab abrogates macrophage-mediated HIV-1 infection and depletion of CD4+ T lymphocytes in hu-SCID mice. Proceedings of the National Academy of Sciences, USA 100, 8927-32.
15. Shi, B., De Girolami, U., He, J. et al. (1996). Apoptosis induced by HIV-1 infection of the central nervous system. Journal of Clinical Investigation 98, 1979-90.
16. Aquaro, S., Panti, S., Caroleo, M. C. et al. (2000). Primary macrophages infected by human immunodeficiency virus trigger CD95-mediated apoptosis of uninfected astrocytes. Journal of Leukocyte Biology 68, 429-35.
17. Mollace, V., Salvemini, D., Riley, D. P. et al. (2002). The contribution of oxidative stress in apoptosis of human-cultured astroglial cells induced by supernatants of HIV-1-infected macrophages. Journal of Leukocyte Biology 71, 65-72.
18. Bagnarelli, P., Valenza, A., Menzo, S. et al. (1996). Dynamics and modulation of human immunodeficiency virus type 1 transcripts in vitro and in vivo. Journal of Virology 70, 7603-13.
19. Gendelman, H. E., Orenstein, J. M., Martin, M. A. et al. (1988). Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. Journal of Experimental Medicine 167, 1428-41.
20. Orenstein, J. M., Meltzer, M. S., Phipps, T. et al. (1988). Cytoplasmic assembly and accumulation of human immunodeficiency virus types 1 and 2 in recombinant human colony-stimulating factor-1-treated human monocytes: an ultrastructural study. Journal of Virology 62, 2578-86.
21. Aquaro, S., Bagnarelli, P., Guenci, T. et al. (2002). Long-term survival and virus production in human primary macrophages infected by human immunodeficiency virus. Journal of Medical Virology 68, 479-88.
22. Garaci, E., Caroleo, M. C., Aloe, L. et al. (1999). Nerve growth factor is an autocrine factor essential for the survival of macrophages infected with HIV. Proceedings of the National Academy of Sciences, USA 96, 14013-8.
23. Perno, C. F., Yarchoan, R., Cooney, D. A. et al. (1988). Inhibition of human immunodeficiency virus (HIV-1/HTLV-IIIBa-L) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2′,3′-dideoxynucleosides. Journal of Experimental Medicine 168, 1111-25.
24. O'Brien, W. A., Namazi, A., Kalhor, H. et al. (1994). Kinetics of human immunodeficiency virus type 1 reverse transcription in blood mononuclear phagocytes are slowed by limitations of nucleotide precursors. Journal of Virology 68, 1258-63.
25. Hao, Z., Cooney, D. A., Hartman, N. R. et al. (1988). Factors determining the activity of 2′,3′-dideoxynucleosides in suppressing human immunodeficiency virus in vitro. Molecular Pharmacology 34, 431-5.
26. Perno, C. F., Yarchoan, R., Balzarini, J. et al. (1992). Different pattern of activity of inhibitors of the human immunodeficiency virus in lymphocytes and monocyte/macrophages. Antiviral Research 17, 289-304.
27. Aquaro, S., Calio, R., Balzarini, J. et al. (2002). Macrophages and HIV infection: therapeutical approaches toward this strategic virus reservoir. Antiviral Research 55, 209-25.
28. Aquaro, S., Perno, C. F., Balestra, E. et al. (1997). Inhibition of replication of HIV in primary monocyte/macrophages by different antiviral drugs and comparative efficacy in lymphocytes. Journal of Leukocyte Biology 62, 138-43.
29. Wainberg, M. A., Salomon, H., Gu, Z. et al. (1995). Development of HIV-1 resistance to (-)2′-deoxy-3′-thiacytidine in patients with AIDS or advanced AIDS-related complex. AIDS 9, 351-7.
30. Miller, M. D., Anton, K. E., Mulato, A. S. et al. (1999). Human immunodeficiency virus type 1 expressing the lamivudine-associated M184V mutation in reverse transcriptase shows increased susceptibility to adefovir and decreased replication capability in vitro. Journal of Infectious Diseases 179, 92-100.
31. Schuurman, R., Nijhuis, M., van Leeuwen, R. et al. (1995). Rapid changes in human immunodeficiency virus type 1 RNA load and appearance of drug-resistant virus populations in persons treated with lamivudine (3TC). Journal of Infectious Diseases 171, 1411-9.
32. Kuritzkes, D. R., Quinn, J. B., Benoit, S. L. et al. (1996). Drug resistance and virologic response in NUCA 3001, a randomized trial of lamivudine (3TC) versus zidovudine (ZDV) versus ZDV plus 3TC in previously untreated patients. AIDS 10, 975-81.
33. Perno, C. F. & Yarchoan, R. (1993). Culture of HIV in monocytes and macrophages. In Current Protocols in Immunology, vol. 3 (Coligan, J. E., Kruisbeek, A. M., Margulies, D. H. et al., Eds), pp. 12.4. 1-11. John Wiley & Sons, New York, NY, USA.
34. Perno, C. F., Yarchoan, R., Cooney, D. A. et al. (11989). Replication of human immunodeficiency virus in monocytes. Granulocyte/macrophage colony-stimulating factor (GM-CSF) potentiates viral production yet enhances the antiviral effect mediated by 3′-azido-2′3′-dideoxythymidine (AZT) and other dideoxynucleoside congeners of thymidine. Journal of Experimental Medicine 169, 933-51.
35. Balzarini, J., Pelemans, H., Karlsson, A. et al. (1996). Concomitant combination therapy for HIV infection preferable over sequential therapy with 3TC and non-nucleoside reverse transcriptase inhibitors. Proceedings of the National Academy of Sciences, USA 93, 13152-7.
36. Toohey, K., Wehrly, K., Nishio, J. et al. (1995). Human immunodeficiency virus envelope V1 and V2 regions influence replication efficiency in macrophages by affecting virus spread. Virology 213, 70-9.
37. Aquaro, S., Calio, R., Balestra, E. et al. (1998). Clinical implications of HIV dynamics and drug resistance in macrophages. Journal of Biological Regulators and Homeostatic Agents 12, 23-7.
38. Richman, D. D., Kornbluth, R. S. & Carson, D. C. (1987). Failure of dideoxynucleosides to inhibit human immunodeficiency virus replication in cultured human macrophages. Journal of Experimental Medicine 166, 1144-9.
39. Sei, S., Stewart, S. K., Farley, M. et al. (1996). Evaluation of human immunodeficiency virus (HIV) type 1 RNA levels in cerebrospinal fluid and viral resistance to zidovudine in children with HIV encephalopathy. Journal of Infectious Diseases 174, 1200-6.
40. Cunningham, P. H., Smith, D. G., Satchell, C. et al. (2000). Evidence for independent development of resistance to HIV-1 reverse transcriptase inhibitors in the cerebrospinal fluid. AIDS 14, 1949-54.
41. Tang, Y. W., Huong, J. T., Lloyd, R. M. et al. (2000). Comparison of human immunodeficiency virus type 1 RNA sequence heterogeneity in cerebrospinal fluid and plasma. Journal of Clinical Microbiology 38, 4637-9.
42. Venturi, G., Catucci, M., Romano, L. et al. (2000). Antiretroviral resistance mutations in human immunodeficiency virus type 1 reverse transcriptase and protease from paired cerebrospinal fluid and plasma samples. Journal of Infectious Diseases 181, 740-5.
43. Lanier, E. R., Sturge, G., McClernon, D. et al. (2001). HIV-1 reverse transcriptase sequence in plasma and cerebrospinal fluid of patients with AIDS dementia complex treated with Abacavir. AIDS 15, 747-51.
44. Bestetti, A., Presi, S., Pierotti, C. et al. (2004). Long-term virological effect of highly active antiretroviral therapy on cerebrospinal fluid and relationship with genotypic resistance. Journal of Neurovirology 10, Suppl. 1, 52-7.
45. Kaul, M., Garden, G. A. & Lipton, S. A. (2001). Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410, 988-94.
46. Kuritzkes, D. R. (1996). Clinical significance of drug resistance in HIV-1 infection. AIDS 10, Suppl. 5, 27-31.
47. Boyer, P. L. & Hughes, S. H. (1995). Analysis of mutations at position 184 in reverse transcriptase of human immunodeficiency virus type 1. Antimicrobial Agents and Chemotherapy 39, 1624-8.
48. Back, N. K., Nijhuis, M., Keulen, W. et al. (1996). Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme. EMBO Journal 15, 4040-9.
49. Sharma, P. L. & Crumpacker, C. S. (1999). Decreased processivity of human immunodeficiency virus type 1 reverse transcriptase (RT) containing didanosine-selected mutation Leu74Val: a comparative analysis of RT variants Leu74Val and lamivudine-selected Met184Val. Journal of Virology 73, 8448-56.
50. Huang, H., Chopra, R., Verdine, G. L. et al. (1998). Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance. Science 282, 1669-75.